Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

Gynuity Health Projects172 enrolled

Overview

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.

Study Type

OBSERVATIONAL

Enrollment

172

Conditions

Other Abortion

Eligibility

Sex: FEMALEHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Having an ongoing pregnancy of 13-22 weeks gestation * Be willing to undergo surgical completion if necessary * Have no contraindications to study procedures, according to provider * Be willing and able to consent to participate in the study * Be willing to follow study procedures Exclusion Criteria: * Known allergy to mifepristone or misoprostol/prostaglandin * Any contraindications to vaginal delivery, including placenta previa * Unable to provide consent

Locations (3)

Odessa Regional Hospital

Odesa, Ukraine

Poltava City Maternity Hospital

Poltava, Ukraine

Vinnitsa Regional Hospital

Vinnitsa, Ukraine

Outcomes

Primary Outcomes

Rate of successful abortion

Time frame: 15 hours after start of misoprostol induction

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.